US Stock MarketDetailed Quotes

TEVA Teva Pharmaceutical Industries

Watchlist
  • 15.695
  • +0.675+4.49%
Trading Apr 29 15:04 ET
18.00BMarket Cap-10.82P/E (TTM)

About Teva Pharmaceutical Industries Company

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: United States, Europe, and International Markets. The United States segment focuses on therapeutic area of central nervous system (CNS) portfolio, and is involved in the distribution business of generic, biosimilar and medicines, and over-the-counter (OTC) pharmaceutical products from the firm and third-party manufacturers to independent retail pharmacies, pharmacy retail chains, hospitals, and physician offices in the United States. The Europe segment offers OTC portfolio including SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brands in European Union, the United Kingdom, and certain other European countries. The International Markets segment provides its products to countries such as Canada, Israel, Russia, Latin America, and Japan. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.

Company Profile

SymbolTEVA
Company NameTeva Pharmaceutical Industries
Listing DateMay 30, 2012
Founded1901
CEOMr. Richard D. Francis
MarketNYSE
Employees36830
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
Address124 Dvora HaNevi'a Street
CityTel Aviv
ProvinceTel Aviv
CountryIsrael
Zip Code6944020
Phone972-3-914-8213

Company Executives

  • Name
  • Position
  • Salary
  • Richard D. Francis
  • Director, President and Chief Executive Officer
  • 15.52M
  • Placid Jover
  • Executive Vice President and Chief Human Resources Officer
  • --
  • Eli Kalif
  • Executive Vice President and Chief Financial Officer
  • 6.18M
  • David R. McAvoy
  • Executive Vice President and Chief Legal Officer
  • --
  • Dr. Eric A Hughes, M.D.,PhD
  • Executive Vice President, Global Research and Development and Chief Medical Officer
  • 5.75M
  • Christine Fox
  • Executive Vice President, U.S. Commercial
  • 5.22M
  • Richard Daniell
  • Executive Vice President, European Commercial
  • 5.43M
  • Matthew Shields
  • Executive Vice President, Global Operations
  • --
  • Mark Sabag
  • Executive Vice President, International Markets Commercial
  • --
  • Evan Lippman
  • Executive Vice President, Business Development
  • --
  • Dr. Sol J. Barer,PhD
  • Chairman of the Board
  • 539.99K
  • Professor Varda Shalev
  • Independent Director
  • 309.99K
  • Professor Ronit Satchi-Fainaro
  • Independent Director
  • 319.99K
  • Rosemary A. Crane, M.B.A.
  • Independent Director
  • 329.99K
  • Janet S. Vergis
  • Independent Director
  • 334.99K
  • Roberto A. Mignone
  • Independent Director
  • 339.99K
  • Gerald M. Lieberman
  • Independent Director
  • 354.99K
  • Chen Lichtenstein
  • Independent Director
  • 93.32K
  • Amir Elstein
  • Independent Director
  • 339.99K
  • Dr. Tal Zaks, M.D.,PhD
  • Independent Director
  • 329.99K
  • Dr. Perry D. Nisen
  • Independent Director
  • 334.99K

Market Insights

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Unlock Now

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.